FCM Investments’s Bristol-Myers Squibb BMY Stock Holding History

FCM Investments’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$37K	Hold	610	–	–	0.05%	27
2017 Q3	$39K	Buy	+610	New	+$35.6K	0.05%	29
2017 Q2	–	Sell	-610	Closed	-$33K	–	55
2017 Q1	$33K	Hold	610	–	–	0.02%	82
2016 Q4	$36K	Hold	610	–	–	0.02%	90
2016 Q3	$33K	Hold	610	–	–	0.02%	84
2016 Q2	$45K	Hold	610	–	–	0.03%	82
2016 Q1	$39K	Hold	610	–	–	0.02%	80
2015 Q4	$42K	Hold	610	–	–	0.02%	85
2015 Q3	$36K	Hold	610	–	–	0.02%	84
2015 Q2	$41K	Hold	610	–	–	0.02%	82
2015 Q1	$39K	Hold	610	–	–	0.02%	82
2014 Q4	$36K	Hold	610	–	–	0.02%	86
2014 Q3	$31K	Hold	610	–	–	0.01%	86
2014 Q2	$30K	Hold	610	–	–	0.01%	89
2014 Q1	$32K	Hold	610	–	–	0.01%	86
2013 Q4	$32K	Sell	610 -38,350	-98%	-$1.95M	0.01%	103
2013 Q3	$1.8M	Sell	38,960 -100	-0.3%	-$4.39K	0.72%	28
2013 Q2	$1.75M	Buy	+39,060	New	+$1.7M	0.78%	24

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

FCM Investments's BMY Position: Q4 2017 in Review

FCM Investments held its Bristol-Myers Squibb (BMY) position steady in Q4 2017 at 610 shares worth $37K. The position accounts for 0.05% of the portfolio, ranked #27.

FCM Investments first reported a position in BMY in Q2 2013 and has held it in 18 quarters since. The position peaked at $1.8M in Q3 2013. 1,736 funds tracked by Wall St. Rank hold BMY as of Q4 2017.

FCM Investments held 610 shares of Bristol-Myers Squibb worth $37K as of Q4 2017.
FCM Investments left its Bristol-Myers Squibb share count unchanged in Q4 2017.
Bristol-Myers Squibb made up 0.05% of FCM Investments's portfolio in Q4 2017, its #27 holding.
FCM Investments first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 18 quarters since.
FCM Investments's Bristol-Myers Squibb position peaked at $1.8M in Q3 2013.
1,736 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2017.

Based on FCM Investments's 13F filing for Q4 2017, filed 17 Jan 2018.